Heat-shock protein 90 inhibitors in antineoplastic therapy: is it all wrapped up?

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.6, 2005-06, pp. : 569-589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

By Patel Hardik J Modi Shanu Chiosis Gabriela Taldone Tony

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 559-587

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an update

By Neckers Len Neckers Katharine

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

By Neckers Len Neckers Katharine

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 277-288

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010

By Messaoudi Samir Peyrat Jean-François Brion Jean-Daniel Alami Mouad

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 10, 2011-10 ,pp. : 1501-1542

Informa Healthcare

Access to resources Recommend Favorite

Post-translational modification of heat-shock protein 90: impact on chaperone function

By Scroggins Bradley T Neckers Len

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1403-1414

Informa Healthcare

Access to resources Recommend Favorite